
Tirzepatide (Research Standard)
Dual GIP and GLP-1 receptor agonist research standard with confirmed chromatographic purity.

High-purity lyophilized Tirzepatide 50mg sterile vial, dual GIP/GLP-1 receptor agonist research grade.
Laboratory Research Disclaimer: This chemical compound is sold strictly for analytical, in vitro, and laboratory research investigations. Not approved for human or veterinary administration.
Certified analytical research vials in 21 verified packaging specifications. Direct B2B batch allocation available.
| Cat. No | Configuration / Name | Packaging Spec | Purity / QC | Stock Status | Actions |
|---|---|---|---|---|---|
| TIRZEPATIDE-RESEARCH-STANDARD | Tirzepatide (Research Standard) | Lyophilized Powder, Sterile Sealed Vial | 99.714%; 99.746%. | In Stock (-20°C) | |
| TR100 | Tirzepatide 100mg (Cat.No: TR100) | 100mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR100 | Tirzepatide 100mg*10vials (TR100) | 100mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR10 | Tirzepatide 10mg (Cat.No: TR10) | 10mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR10 | Tirzepatide 10mg*10vials (TR10) | 10mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR120 | Tirzepatide 120mg (Cat.No: TR120) | 120mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR120 | Tirzepatide 120mg*10vials (TR120) | 120mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR15 | Tirzepatide 15mg (Cat.No: TR15) | 15mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR15 | Tirzepatide 15mg*10vials (TR15) | 15mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR20 | Tirzepatide 20mg (Cat.No: TR20) | 20mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR20 | Tirzepatide 20mg*10vials (TR20) | 20mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR30 | Tirzepatide 30mg (Cat.No: TR30) | 30mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR30 | Tirzepatide 30mg*10vials (TR30) | 30mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR40 | Tirzepatide 40mg (Cat.No: TR40) | 40mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR40 | Tirzepatide 40mg*10vials (TR40) | 40mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR50 | Tirzepatide 50mg (Cat.No: TR50)Current Selection | 50mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR50 | Tirzepatide 50mg*10vials (TR50) | 50mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR5 | Tirzepatide 5mg (Cat.No: TR5) | 5mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR5 | Tirzepatide 5mg*10vials (TR5) | 5mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) | |
| TR60 | Tirzepatide 60mg (Cat.No: TR60) | 60mg Lyophilized Powder / Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| TR60 | Tirzepatide 60mg*10vials (TR60) | 60mg*10vials | ≥99.0% (HPLC) | In Stock (-20°C) |
Research-grade synthetic Tirzepatide, Cat.No: TR50, 50mg/vial. Validated by RP-HPLC and ESI-MS with purity ???99.0%. Lyophilized powder in sterile glass vial with tamper-evident seal.
Reconstitution & Stability Guidance: Lyophilized peptides should be equilibrated to room temperature before reconstitution. Spin vial gently to ensure all powder is at the bottom. Reconstitute using sterile bacteriostatic or deionized water according to your experimental protocol. Reconstituted solutions should be aliquoted to avoid repeated freeze-thaw cycles and maintained at -20°C or below.

Dual GIP and GLP-1 receptor agonist research standard with confirmed chromatographic purity.

High-purity lyophilized Tirzepatide 10mg sterile vial, dual GIP/GLP-1 receptor agonist research grade.

High-purity lyophilized Tirzepatide 100mg sterile vial, dual GIP/GLP-1 receptor agonist research grade.